Presima Securities ULC Sells 287,061 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Presima Securities ULC lowered its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 29.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 695,216 shares of the real estate investment trust’s stock after selling 287,061 shares during the quarter. Healthpeak Properties comprises 3.5% of Presima Securities ULC’s portfolio, making the stock its 13th biggest holding. Presima Securities ULC’s holdings in Healthpeak Properties were worth $14,092,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. HM Payson & Co. purchased a new stake in shares of Healthpeak Properties during the third quarter valued at $25,000. S.A. Mason LLC purchased a new position in shares of Healthpeak Properties during the third quarter worth approximately $26,000. Rise Advisors LLC bought a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $29,000. Fortitude Family Office LLC purchased a new stake in shares of Healthpeak Properties in the third quarter valued at approximately $32,000. Finally, Barrett & Company Inc. bought a new position in Healthpeak Properties in the third quarter worth approximately $33,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

DOC opened at $20.82 on Friday. The firm’s 50-day moving average price is $20.83 and its 200-day moving average price is $21.53. The company has a market cap of $14.56 billion, a P/E ratio of 44.29, a price-to-earnings-growth ratio of 2.21 and a beta of 1.14. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The firm had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. During the same period in the prior year, the company posted $0.45 earnings per share. The firm’s revenue for the quarter was up 25.9% on a year-over-year basis. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.81 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have weighed in on DOC. Wells Fargo & Company lowered their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Mizuho reduced their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Royal Bank of Canada upped their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, Robert W. Baird boosted their price objective on shares of Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.